SLU-PP-332 is a synthetic small molecule investigated as an agonist of the estrogen-related receptor (ERR) family of nuclear receptors. It has attracted research interest as a chemical probe for studying ERR-dependent transcription, mitochondrial biology, oxidative metabolism, and tissue-specific metabolic signaling in experimental systems.

Rather than characterizing SLU-PP-332 according to desired physiological outcomes, this guide focuses on its molecular targets, signaling pathways, experimental applications, and published preclinical research.

All information presented here is strictly for scientific and laboratory research purposes.

What Is SLU-PP-332?

SLU-PP-332 is a research compound developed for the study of estrogen-related receptors, particularly:

• ERRα (ESRRA)
• ERRβ (ESRRB)
• ERRγ (ESRRG)

Despite their name, estrogen-related receptors are distinct from classical estrogen receptors. ERRs are generally classified as orphan nuclear receptors and do not function through estrogen binding in the same manner as ERα and ERβ.

ERRs participate in transcriptional networks associated with cellular energy metabolism, mitochondrial function, oxidative pathways, and tissue-specific gene regulation.

SLU-PP-332 has been characterized in published experimental research as a pan-ERR agonist, making it useful as a chemical probe for examining these receptor systems.

Estrogen-Related Receptors and Cellular Metabolism

ERRs function as transcription factors. Their activity can influence the expression of numerous genes involved in cellular energy pathways.

Researchers have investigated ERR-associated regulation of pathways involving:

• Mitochondrial oxidative metabolism
• Oxidative phosphorylation
• Fatty-acid metabolism
• Cellular substrate utilization
• Mitochondrial gene-expression networks
• ATP-associated metabolic pathways

ERR signaling is also closely associated with transcriptional co-regulators, including PGC-1α (PPARGC1A).

Because these pathways interact with multiple metabolic systems, SLU-PP-332 provides researchers with a tool for investigating how pharmacological activation of ERRs alters downstream transcription under controlled experimental conditions.

Mechanism of Action

The primary research interest surrounding SLU-PP-332 is its interaction with the ERR family of nuclear receptors.

Unlike cell-surface receptors that produce rapid second-messenger responses, nuclear receptors primarily regulate biological activity through changes in transcription.

A simplified experimental model is:

SLU-PP-332 → ERR activation → transcriptional regulation → altered expression of ERR-responsive genes

Researchers can examine this pathway using molecular and biochemical techniques that measure receptor activity and subsequent changes in gene expression.

ERRα and PGC-1α Signaling

ERRα is frequently investigated alongside PGC-1α, a transcriptional coactivator involved in metabolic gene-expression networks.

PGC-1α can interact with ERRα and influence transcription of genes associated with mitochondrial and oxidative pathways.

Experimental investigation of this relationship may involve measurements of:

• ESRRA expression
• PPARGC1A expression
• ERR-responsive transcription
• Mitochondrial-associated gene expression
• Oxidative phosphorylation genes
• Metabolic enzyme expression
• Cellular oxygen-consumption parameters

SLU-PP-332 can therefore serve as a research probe for studying how ERR activation affects these molecular networks.

Mitochondrial Research

One major area of SLU-PP-332 research involves mitochondrial biology.

Published preclinical studies have examined changes in metabolic and mitochondrial-associated pathways following experimental ERR activation.

Laboratory endpoints may include:

• Mitochondrial gene-expression profiles
• Mitochondrial content markers
• Electron transport chain proteins
• Oxygen consumption rate (OCR)
• ATP-associated respiration
• Basal and maximal respiration
• Mitochondrial membrane-associated measurements
• Oxidative enzyme expression

These measurements allow researchers to characterize changes in cellular bioenergetics without converting experimental observations into claims about human outcomes.

Lipid and Substrate Metabolism Research

ERRs participate in transcriptional regulation of genes associated with lipid metabolism and cellular substrate utilization.

Accordingly, investigators have used SLU-PP-332 and related ERR agonists to examine changes in pathways involving:

• Fatty-acid transport
• Fatty-acid oxidation
• Lipid-associated gene expression
• Cellular substrate utilization
• Oxidative metabolism
• Metabolic enzyme activity

Published animal-model findings concerning body composition, adipose tissue, or metabolic phenotypes should be understood as model-specific experimental observations. They do not establish corresponding effects in humans and do not establish an intended use for research materials.

Skeletal Muscle Research

Skeletal muscle provides another experimental system for studying ERR signaling because oxidative metabolism and mitochondrial activity differ substantially among muscle fiber types.

Researchers may examine:

• Oxidative enzyme expression
• Mitochondrial markers
• ERR-responsive genes
• Muscle fiber-associated gene-expression patterns
• Metabolic pathway activation
• Tissue oxygen-consumption measurements
• Transcriptional responses to experimental ERR activation

Animal studies may also incorporate standardized physiological measurements as experimental endpoints. Such findings remain specific to the models, protocols, and compounds evaluated in those studies.

Adipose Tissue Research

Published preclinical research has examined SLU-PP-332 in experimental models involving adipose tissue biology.

Relevant laboratory endpoints may include:

• Adipocyte gene-expression profiles
• Mitochondrial-associated markers
• Thermogenic gene-expression pathways
• Oxidative metabolism markers
• Lipid-associated signaling
• ERR-dependent transcription

These experiments can help characterize how ERR activation influences adipocyte biology and metabolic transcriptional networks.

References to animal-model phenotypes should not be interpreted as evidence of an effect in humans or as a proposed application for an RUO compound.

Cardiac and Other Tissue Models

ERRα and ERRγ have also been studied extensively in cardiac biology because of their involvement in transcriptional networks associated with energy-demanding tissues.

Research involving these receptors may examine:

• Cardiac metabolic gene expression
• Mitochondrial pathways
• Oxidative phosphorylation
• Energy-substrate utilization
• Tissue-specific ERR signaling
• Transcriptional regulation

SLU-PP-332 may therefore be useful for experimental investigation of ERR biology across multiple cell and tissue models.

Common Laboratory Research Applications

SLU-PP-332 can be incorporated into research designed to investigate several aspects of ERR biology.

Receptor Pharmacology

Researchers can characterize activation of ERRα, ERRβ, and ERRγ using appropriate receptor and transcriptional assays.

Gene-Expression Studies

Quantitative PCR, RNA sequencing, and related techniques can be used to evaluate changes in ERR-responsive transcription.

Cellular Bioenergetics

Metabolic flux and respirometry platforms can measure oxygen consumption and other parameters associated with cellular energy metabolism.

Mitochondrial Biology

Researchers can evaluate mitochondrial-associated proteins, gene-expression profiles, enzyme activity, and other biochemical markers.

Tissue-Specific Signaling

Cell cultures, isolated tissues, and validated animal models can be used to investigate differences in ERR-dependent signaling among experimental systems.

Experimental Methods

The appropriate analytical methods depend on the scientific question being investigated.

Potential approaches include:

Reporter assays: Reporter systems can be used to characterize ERR-dependent transcriptional activity.

Quantitative PCR: qPCR can measure changes in expression of selected ERR-responsive genes.

RNA sequencing: Transcriptomic analysis can provide broader characterization of gene-expression changes following experimental receptor activation.

Western blotting: Protein-expression changes can be evaluated for selected metabolic and mitochondrial markers.

Cellular respirometry: Oxygen-consumption and related bioenergetic parameters can be measured using appropriate analytical platforms.

Receptor assays: Validated receptor assays can characterize functional agonist activity and receptor selectivity.

Experimental Design Considerations

Results involving SLU-PP-332 should be interpreted within the context of the particular experimental system.

Variables that may influence findings include:

• Cell type
• Tissue type
• ERR isoform expression
• Experimental controls
• Compound identity and purity
• Experimental concentration
• Exposure duration
• Culture conditions
• Assay methodology
• Analytical sensitivity
• Biological and technical replicates

Researchers should use appropriate positive and negative controls and validated analytical methods when investigating receptor-dependent activity.

Analytical Characterization of Research Material

Chemical characterization is an important component of small-molecule research.

Depending on the application, researchers may evaluate:

• Chemical identity
• Molecular mass
• Chromatographic purity
• Chemical stability
• Degradation products
• Solubility under defined experimental conditions

Analytical techniques may include HPLC, LC-MS, NMR spectroscopy, or other methods appropriate to the compound and experimental objective.

Published Research

SLU-PP-332 and ERR signaling have been examined in peer-reviewed preclinical research. The following publications provide useful background:

1. Billon, C., et al. Research characterizing SLU-PP-332 as a chemical probe and agonist of estrogen-related receptors.
2. Cyphert, T. J., et al. (2023). Research examining pan-ERR agonism and adipose-tissue-associated metabolic phenotypes in experimental models. Nature Communications.
3. Dufour, C. R., et al. (2007). Research concerning ERRα and ERRγ regulation of cardiac transcriptional networks. Cell Metabolism.
4. Eichner, L. J., & Giguère, V. (2011). Research reviewing estrogen-related receptors and metabolic regulation. Journal of Endocrinology.
5. Lim, H. W., et al. (2015). Research examining ERRα genomic binding and genes associated with oxidative metabolism. PLOS ONE.
6. Wang, T., et al. (2022). Research concerning small-molecule activation of estrogen-related receptors. ACS Chemical Biology.

These references describe findings from specific experimental systems. Published findings involving animals, cells, or isolated tissues should not be extrapolated beyond the conditions under which they were observed.

Research Use Only

SLU-PP-332 offered by PeakForce Labs is intended strictly for laboratory research use only (RUO).

It is not intended for human or veterinary use, personal use, medical or therapeutic use, diagnostic use, or administration to humans or animals.

PeakForce Labs does not provide dosing, administration, injection, ingestion, personal reconstitution, or treatment instructions for research materials.

Researchers are responsible for ensuring that acquisition, storage, handling, experimentation, and disposal are conducted in accordance with applicable institutional policies, laboratory procedures, and federal, state, and local requirements.